Feeds › Merger clearances (HSR)
Merger clearances (HSR)
Mergers and acquisitions the FTC and Justice Department cleared early under the Hart-Scott-Rodino Act, with the public companies among them. Granted requests only.
About this data
- What it is
- Companies planning a merger or acquisition above a size threshold must tell the FTC and the Justice Department first and wait 30 days before closing (the Hart-Scott-Rodino Act). The parties can ask for that wait to end early, and when the agencies agree, the FTC publishes an early termination notice. This feed lists those notices: the buyer, the target, the entities being acquired and the day early termination was granted. We match each name to a public company when it lines up.
- Who files it
- The FTC, which publishes a notice once it and the Department of Justice have granted the request.
- How current
- We check the FTC's list every day. A notice is published when early termination is granted, which is before the deal closes.
- Terms
- Hart-Scott-RodinoThe Hart-Scott-Rodino Act requires companies planning a merger or acquisition above a size threshold to tell the FTC and the Justice Department first and wait 30 days before closing, so the agencies can look for competition problems.Early terminationThe parties can ask for that waiting period to end sooner. When the agencies agree, the FTC publishes an early termination notice. It means the deal was cleared to close early, not that the agencies endorse it.Possible matchWe match each name to a public company automatically. A name that matches closely is shown as a company; a looser match is marked "possible match" because a similar name, a subsidiary or a differently spelled name can be matched wrongly. Most parties are private companies and funds and have no match.
- Worth knowing
- This is a partial list of deals, not every merger. Only requests that were granted appear: deals that waited out the full 30 days, deals whose request was refused and deals that were never reportable are not listed. The FTC granted no early terminations from February 2021 until the new HSR form took effect in February 2025, so there is nothing between those dates. A notice does not mean the agencies endorse a deal, and it does not say whether the deal closed. Most buyers and targets are private companies, funds or people. We match names to public companies automatically; a looser match is marked "possible match" because a similar name, a subsidiary or a differently spelled name can be matched wrongly.
This comes from the FTC's list of early-termination notices.
Source and freshness · Information, not investment advice (disclaimer).
Early terminations granted per month, last 24 months
Only granted requests are listed, not every deal. The FTC granted none from February 2021 until the new HSR form took effect in February 2025.
Latest early terminations granted
Showing: ticker AZN
Only early terminations that were granted are listed, not every deal, and none were granted between February 2021 and February 2025.
| Granted | BuyerThe "acquiring person" in the filing: the ultimate parent entity of the buyer, which can be a company, a fund or a person. We match each name to a public company automatically. A name that matches closely is shown as a company; a looser match is marked "possible match" because a similar name, a subsidiary or a differently spelled name can be matched wrongly. Most parties are private companies and funds and have no match. | TargetThe "acquired person": the ultimate parent entity of the target. The entities actually being acquired are listed under it. | Transaction | Source |
|---|---|---|---|---|
| Jun 24, 2025 | AstraZeneca plc | Pathos AI, Inc. | 20251330 | FTC ↗ |
| Sep 9, 2019 | AstraZeneca plc | Swedish Orphan Biovitrum AB (publ) EmaCo SA | 20191928 | FTC ↗ |
| Apr 6, 2017 | Circassia Pharmaceuticals plc | AstraZeneca plc AstraZeneca UK Limited | 20170937 | FTC ↗ |
| Mar 10, 2017 | GTCR Fund Xi/B LP | AstraZeneca plc AstraZeneca UK Limited | 20170832 | FTC ↗ |
| Nov 7, 2016 | Allergan plc | AstraZeneca plc AstraZeneca Collaboration Ventures, LLC | 20170071 | FTC ↗ |
| Oct 27, 2016 | Aralez Pharmaceuticals Inc. | AstraZeneca plc AstraZeneca AB | 20170072 | FTC ↗ |
| Jun 2, 2016 | Ironwood Pharmaceuticals, Inc. | AstraZeneca plc Ardea Biosciences, Inc. | 20161126 | FTC ↗ |
| Jan 19, 2016 | AstraZeneca plc | Acerta Pharma B.V. | 20160546 | FTC ↗ |
| Dec 10, 2015 | Perrigo Company plc | AstraZeneca plc AstraZeneca AB | 20160377 | FTC ↗ |
| Nov 24, 2015 | AstraZeneca plc | ZS Pharma, Inc. | 20160281 | FTC ↗ |
| Aug 26, 2015 | AstraZeneca plc | Nadine & Samuel Wohlstadter Wellstat Therapeutics Corporation | 20151528 | FTC ↗ |
| Aug 21, 2015 | AstraZeneca plc | Amgen Inc. | 20151525 | FTC ↗ |
| Jun 4, 2015 | AstraZeneca plc | Innate Pharma S.A. | 20151018 | FTC ↗ |
| Feb 26, 2015 | AstraZeneca plc | Actavis plc Forest Laboratories, LLC; Forest Laboratories Canada, Inc. and 1 more | 20150616 | FTC ↗ |
| Feb 11, 2015 | AstraZeneca plc | Bristol-Myers Squibb Company | 20150511 | FTC ↗ |
| Jan 8, 2014 | AstraZeneca plc | Bristol-Myers Squibb Company BMS Holdco, Inc.; Amylin Pharmaceuticals, LLC | 20140375 | FTC ↗ |
| Sep 24, 2013 | AstraZeneca plc | Amplimmune, Inc. | 20131259 | FTC ↗ |
| Jun 26, 2013 | AstraZeneca plc | Omthera Pharmaceuticals, Inc. | 20130924 | FTC ↗ |
| Jun 24, 2013 | AstraZeneca plc | Vatera Investment Partners LLC Pearl Therapeutics, Inc. | 20130958 | FTC ↗ |
| Nov 2, 2011 | AstraZeneca plc | Pfizer Inc. | 20120044 | FTC ↗ |
| Dec 29, 2009 | AstraZeneca plc | Targacept, Inc. | 20100247 | FTC ↗ |
| Oct 8, 2009 | AstraZeneca plc | Nektar Therapeutics | 20090768 | FTC ↗ |
| May 29, 2007 | AstraZeneca plc | Medlmmune, Inc. | 20071303 | FTC ↗ |
| Jul 17, 2006 | AstraZeneca plc | Abbott Laboratories Abbott Pharmaceuticals PR Ltd. | 20061389 | FTC ↗ |
| Jan 27, 2006 | AstraZeneca plc | AtheroGenics, Inc. | 20060436 | FTC ↗ |
| Jan 20, 2006 | AstraZeneca plc | Targacept, Inc. | 20060435 | FTC ↗ |
| Jan 27, 2005 | Eli Lilly and Company | AstraZeneca Plc IPR Pharmaceuticals, Inc. | 20050466 | FTC ↗ |
| Feb 26, 2002 | First Horizon Pharmaceutical Corporation | AstraZeneca plc AstraZeneca UK Limited | 20020458 | FTC ↗ |
| Aug 3, 2001 | aaiPharma Inc. | AstraZeneca plc | 20012202 | FTC ↗ |
| Feb 13, 2001 | Dentsply International Inc. | AstraZeneca plc AstraZeneca AB | 20011391 | FTC ↗ |
| Nov 1, 2000 | AstraZeneca plc | Novartis US Co. | 20001485 | FTC ↗ |
31 items, most recent first (up to 50). Each row links to the FTC page that lists the notices; the transaction number identifies it there. Updated Nov 15, 2026, 6:16 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances